Actively Recruiting
Medical Honey for Wound Treatment in Intensive Care. (MICARéa) Randomized, Controlled, Single-center Pilot Study.
Led by University Hospital, Angers · Updated on 2026-04-06
60
Participants Needed
1
Research Sites
198 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Wound management is a real public health issue in France. To date, a wide range of devices exists to treat these wounds, depending on their nature and stage of evolution. Honey has been proposed for the care of wounds and is effective in reducing the surface of wounds and the pain perceived by patients. Inanition, its use is very simple compared to usual care, requiring different types of dressing accross time. In the intensive care unit, patients are prone to suffering or developing numerous types of wound, but the interest of honey has not been investigated yet. We propose a prospective, monocentric, randomized, single-blind, controlled clinical trial to assess the efficacy of managing acute cutaneous wounds with honey (Activon®) compared with standard care, in intensive care patients. The primary endpoint is the percentage of wound surface area reduction measured at 15 days from inclusion.
CONDITIONS
Official Title
Medical Honey for Wound Treatment in Intensive Care. (MICARéa) Randomized, Controlled, Single-center Pilot Study.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Hospitalized in surgical intensive care unit A -USC PTO CHU ANGERS
- Signed informed consent by patient or relative (or emergency inclusion procedure)
- One or more wounds at least 4 cm2 in size, evolving for less than 8 days, including stage 2, 3, 4 pressure sores, lacerations, ulcers, dermabrasions, and scar disunions
You will not qualify if you...
- Honey intolerance or allergy to bee stings
- Wounds lasting more than 8 days
- Bleeding wounds
- Tunneled wounds
- Chronic dermatoses
- Estimated life expectancy less than 15 days
- Expected discharge within 48 hours
- No affiliation to a French social security scheme
- Pregnant, breastfeeding, or parturient women
- Person deprived of liberty by judicial or administrative decision
- Person under legal protection measure
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Angers University Hospital, surgical reanimation
Angers, France
Actively Recruiting
Research Team
C
Catherine CR ROD, NURSE
CONTACT
S
Sigismond SL LASOCKI, PUPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here